Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

451 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparing the Prevalence of Polypharmacy and Potential Drug-Drug Interactions in Nursing Homes and in the Community Dwelling Elderly of Emilia Romagna Region.
Burato S, Leonardi L, Antonazzo IC, Raschi E, Ajolfi C, Baraghini M, Chiarello A, Delmonte V, Di Castri L, Donati M, Fadda A, Fedele D, Ferretti A, Gabrielli L, Gobbi S, Lughi S, Mazzari M, Pieraccini F, Renzetti A, Russi E, Scanelli C, Zanetti B, Poluzzi E. Burato S, et al. Among authors: leonardi l. Front Pharmacol. 2021 Feb 11;11:624888. doi: 10.3389/fphar.2020.624888. eCollection 2020. Front Pharmacol. 2021. PMID: 33628186 Free PMC article.
No signal of interactions between influenza vaccines and drugs used for chronic diseases: a case-by-case analysis of the vaccine adverse event reporting system and vigibase.
Carnovale C, Raschi E, Leonardi L, Moretti U, De Ponti F, Gentili M, Pozzi M, Clementi E, Poluzzi E, Radice S. Carnovale C, et al. Among authors: leonardi l. Expert Rev Vaccines. 2018 Apr;17(4):363-381. doi: 10.1080/14760584.2018.1442718. Epub 2018 Mar 9. Expert Rev Vaccines. 2018. PMID: 29452497 Free article.
COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety.
Luxi N, Giovanazzi A, Capuano A, Crisafulli S, Cutroneo PM, Fantini MP, Ferrajolo C, Moretti U, Poluzzi E, Raschi E, Ravaldi C, Reno C, Tuccori M, Vannacci A, Zanoni G, Trifirò G; Ilmiovaccino COVID19 collaborating group. Luxi N, et al. Drug Saf. 2021 Dec;44(12):1247-1269. doi: 10.1007/s40264-021-01131-6. Epub 2021 Nov 5. Drug Saf. 2021. PMID: 34739716 Free PMC article. Review.
Italian Emergency Department Visits and Hospitalizations for Outpatients' Adverse Drug Events: 12-Year Active Pharmacovigilance Surveillance (The MEREAFaPS Study).
Lombardi N, Crescioli G, Bettiol A, Tuccori M, Capuano A, Bonaiuti R, Mugelli A, Venegoni M, Vighi GD, Vannacci A; MEREAFaPS Study group. Lombardi N, et al. Front Pharmacol. 2020 Apr 6;11:412. doi: 10.3389/fphar.2020.00412. eCollection 2020. Front Pharmacol. 2020. PMID: 32327995 Free PMC article.
Chilblains in a child with confirmed SARS-CoV-2 infection: a red flag for late-onset skin manifestation in previously infected individuals.
Neri I, Conti F, Virdi A, Guglielmo A, Leonardi L, Corsini I, Ghizzi C, Gabrielli L, Lazzarotto T, Lanari M, Patrizi A, Misciali C. Neri I, et al. Among authors: leonardi l. J Eur Acad Dermatol Venereol. 2021 Jun;35(6):e357-e359. doi: 10.1111/jdv.17194. Epub 2021 Mar 14. J Eur Acad Dermatol Venereol. 2021. PMID: 33651419 Free PMC article. No abstract available.
451 results